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Human alveolar echinococcosis (AE) is a parasitosis
caused by the larval stage of Echinococcus multilocularis,
a tapeworm belonging to the family Taeniidae [1]. The
adult parasites reside in fox intestines where they produce
eggs released in feces. Eggs are usually ingested by
rodents, the intermediate hosts of the parasite, or
accidentally by humans. After the eggs hatch in the
intestine, the embryos make their way to other organs,
especially the liver, and develop into the larval stage. AE
is a highly pathogenic and potentially fatal chronic liver
infestation that is characterized by a tumor-like multi-
vesicular, infiltrating structure [2]. Early diagnosis can
improve the management and the treatment of affected
patients, and it relies on complementary procedures such
as clinical findings, imaging techniques, hepatic metabolic
marker analysis and immunodiagnosis. Serological tests to
detect AE are similar to those used for cystic echinococ-
cosis (CE) caused by Echinococcus granulosus. These
tests have recently been improved and are generally
known to be more reliable for AE than for CE infection
[1]. Nevertheless, we report a case of asymptomatic
hepatic AE in a patient with normal liver enzymes in
which serological tests resulted negative for conventional
E. multilocularis antibodies.
The patient was a 60-year-old woman who had lived in
the Savoy region (French Alps) for 10 years. In 1994 a
hepatic nodule with a diameter of 20 mm had fortuitously
been discovered, without any accompanying symptom. In
May 2000 the nodule had reached a diameter of 30 mm,
and a hepatic biopsy was performed with no reliable result.
In December 2002 the nodule had reached 50 mm in
diameter, and echographic control showed a heterogenous
and multicystic lesion in the liver that repulsed the inferior
vena cava, suggesting AE. A second hepatic biopsy was
performed and microscopic laminar fragments character-
istic of echinococcosis (AE or CE) were found.
The patient had never presented any biological
abnormalities (i.e., in liver tests and tumor markers). An
initial serum sample was tested in September 2002 against
both Echinococcus species antigens (i.e., E. granulosus
and E. multilocularis) with counterimmunoelectrophoresis
and the indirect hemagglutination test. Both tests yielded
negative results. In December 2002 a second serum
sample was investigated for E. multilocularis antibodies in
another laboratory using a commercial Em2plus ELISA
assay (Bordier Affinity Products, Crissier, Switzerland).
This ELISA method also yielded negative results. Never-
theless, a second screening technique, a home-made
indirect immunofluorescence antibody test with E. gran-
ulosus protoscoleces, produced a positive reaction. Immu-
noelectrophoresis, performed as a confirmation method,
remained negative. A commercial ELISA to detect E.
granulosus (Bordier Affinity Products) gave a strong
positive result, which pointed the diagnosis in the direction
of CE. At the same time low-grade lymphoma was
detected in the patient; her monoclonal IgM had reached
9 g/l while total Ig had slightly diminished to 6.2 g/l for
IgG (normal range, 6.8–12.6 g/l) and 0.59 g/l for IgA
(normal range, 0.82–2.62 g/l).
In February 2003 the patient underwent a right-sided
hepatectomy. The parasitic lesion, located close to the
inferior vena cava, gripped the diaphragm. It showed
cavitary parasitic alveoli with several lobes, characteristic
of AE. Sera collected successively in March and May
2003 were positive for echinococcosis in the immunoflu-
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orescence antibody test and for E. granulosus in ELISA,
but negative results were still obtained with the Em2plus
ELISA. All of the sera were subsequently sent to a
reference laboratory for confirmation of the negative
Em2plus ELISA results (The results of ELISA testing at
both laboratories are summarized in Table 1). Another
E. granulosus ELISA performed as described elsewhere
[3] yielded a positive reaction. Since the Em2plus ELISA
contained an association of Em2 and II/3–10 antigens [3],
each of them was tested separately. While none of the sera
reacted in the Em2-ELISA, except for the first serum
sample that exhibited low antibody reactivity, all four sera
yielded positive results with the II/3–10-ELISA. Western
blot testing against E. granulosus and E. multilocularis
antigens was subsequently carried out, and both results
were positive, demonstrating reactivity to the 8/12 kDa
bands (subunit antigen B) for E. granulosus and the 18
kDa band for E. multilocularis (data not shown). Poly-
merase chain reaction with BG1/BG2 primers was carried
out as described elsewhere [4, 5] with genomic DNA from
the hepatic lesion, and amplicons specific for E. multiloc-
ularis were detected.
This report describes the case of a patient living in a
region well-known to be endemic for AE [2, 6] whose
diagnosis was nonetheless complicated by several factors.
(i) The results of several serological techniques showed
atypical and very low levels of parasite-specific antibody
reactivities, while an important cross-reaction with E.
granulosus was observed (i.e., low anti-E. multilocularis
response, high anti-E. granulosus response, as found in a
previous epidemiological study [7]). The patient was then
able to produce antibodies against certain non-specific
components. (ii) There was a notable absence of clinical
symptoms, such as cholestatic jaundice and/or epigastric
pain, fatigue, weight loss, or hepatomegaly, which have
been mentioned in most previous reports of AE cases [8].
(iii) Liver blood tests failed to produce abnormal results in
spite of a progressive course of AE; in particular, there was
no increase in the levels of alkaline phosphatase and of γ-
glutamyl transpeptidase, and no hypergammaglobuline-
mia, all of which are usually reported in cases of AE [8].
In this case direct biological diagnosis first failed since
the hepatic biopsy sample lacked sufficient and reliable
material for direct and pathological examinations. In the
indirect biological diagnosis, the unusual serological
reaction pattern may have been related to an immuno-
globulin disorder or to interference caused by the mono-
clonal IgM lymphoma. Moreover, the patient’s liver
inflammatory response may have been restricted by
immunosuppression.
Although serodiagnosis is usually a reliable adjunct to
other procedures aimed at detecting AE and differentiating
it from CE [1], this case demonstrates that serological
results must be analyzed carefully in patients suspected to
have AE who also have immunological abnormalities. In
our case, molecular biology as well as direct and
pathological examinations were of interest. It is important
to note that the absence of hepatic disorders does not
exclude progressive AE.
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Table 1 Results of serological testing with two ELISAs to detect
CE and AE (EgHF E. granulosus ELISAwith hydatid fluid antigen,
Em2plusE. multilocularis ELISA with Em2 associated with II/3–10
antigen)
ELISA Date of serum collection (month/year)
09/02 12/02 03/03 05/03
In-house laboratory
ELISA Em2plus Negative Negative Negative Negative
ELISA EgHF Positive Positive Positive Positive
Reference laboratorya
ELISA Em2plus 0 0 0 0
ELISA Em2 1 0 0 0
ELISA II/3–10 48 49 17 18
ELISA EgHF 77 72 53 58
aELISA values were given in antibody units (AU) where 0 is
negative and seropositivity starts at ≥1 (a high positive control is
100 AU). Tests performed in the reference laboratory were carried
out as described by Gottstein et al. [3]
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